Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 12.84B | 11.82B | 11.52B | 11.54B | 11.92B | 11.20B |
Gross Profit | 12.95B | 11.82B | 11.52B | 11.54B | 11.92B | 11.20B |
EBITDA | 1.97B | 0.00 | 2.40B | 2.30B | 2.43B | 2.43B |
Net Income | 1.38B | 1.25B | 1.28B | 1.20B | 990.00M | 1.06B |
Balance Sheet | ||||||
Total Assets | 871.90B | 876.89B | 895.00B | 970.15B | 963.50B | 790.65B |
Cash, Cash Equivalents and Short-Term Investments | 48.86B | 72.28B | 72.49B | 135.22B | 166.10B | 49.81B |
Total Debt | 200.00M | 40.68B | 50.65B | 114.29B | 105.34B | 470.00M |
Total Liabilities | 836.01B | 838.38B | 50.65B | 930.51B | 922.75B | 751.57B |
Stockholders Equity | 35.00B | 37.64B | 35.91B | 38.77B | 39.91B | 38.27B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -10.18B | -93.42B | -34.14B | 113.18B | -2.49B |
Operating Cash Flow | 0.00 | -9.11B | -92.83B | -33.87B | 113.44B | -2.26B |
Investing Cash Flow | 0.00 | 9.42B | 31.35B | 4.58B | 2.13B | 13.88B |
Financing Cash Flow | 0.00 | -6.89B | -384.00M | -378.00M | -378.00M | -380.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
69 Neutral | ¥10.69B | 10.01 | 4.44% | -2.78% | 13.42% | ||
68 Neutral | ¥11.84B | 9.02 | 3.85% | 5.17% | 35.59% | ||
68 Neutral | ¥724.27B | 10.74 | 7.55% | 3.29% | 7.97% | 15.90% | |
62 Neutral | ¥9.05B | 6.80 | 4.48% | 2.13% | 10.94% | ||
61 Neutral | ¥8.32B | 8.63 | 3.28% | -10.59% | -44.94% | ||
50 Neutral | ¥7.85B | ― | 2.22% | 1.71% | -164.25% | ||
41 Neutral | ¥9.23B | 5.93 | 1.45% | 2.89% | -993.38% |